Americord | WebDisclosure

Switch to English

11126	Sociétés
245054	Mots-clés
173176	Articles
132194	Communiqués

Accueil
Sociétés
Americord

BRÈVE

publiée le 23/02/2024 à 16:30, il y a 2 années 7 mois

Americord réalise une avancée dans le traitement de la maladie du motoneurone grâce aux cellules souches du sang de cordon

Americord Cellules Souches Sang De Cordon Maladie Du Motoneurone Traitement
BRÈVE

publiée le 23/02/2024 à 16:30, il y a 2 années 7 mois

Americord makes breakthrough in treating Motor Neuron Disease with cord blood stem cells

Americord Stem Cells Cord Blood Motor Neuron Disease Treatment
COMMUNIQUÉ DE PRESSE

publié le 23/02/2024 à 16:30, il y a 2 années 7 mois

Americord Releases Cord Blood Stem Cells for Treatment of Motor Neuron Disease
Americord releases cord blood stem cells for the treatment of motor neuron disease in India, highlighting the therapeutic potential of stem cells in healthcare

Healthcare Americord Motor Neuron Disease Treatment Cord Blood Stem Cells
COMMUNIQUÉ DE PRESSE

publié le 06/12/2023 à 15:00, il y a 2 années 9 mois

Americord Elevates Standards With Strategic Lab Relocation to Somerset, New Jersey
Americord, a leader in the biobanking industry, has relocated its laboratory from New York City to a state-of-the-art facility in Somerset, New Jersey, marking a milestone in advancing research, product quality, and growth opportunities

Americord Biobanking Laboratory Relocation Research Somerset New Jersey

Les Echos

Publié le 05/10/2026 à 18:13, il y a 3 heures 28 minutes

Disclosure of shares outstanding and voting rights - 05.10.2026
Publié le 05/10/2026 à 18:13, il y a 3 heures 28 minutes

Déclaration nombre d'actions et droits de vote - 05.10.2026
Publié le 05/10/2026 à 18:00, il y a 3 heures 41 minutes

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 30 septembre 2026
Publié le 05/10/2026 à 17:45, il y a 3 heures 56 minutes

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 05/10/2026 à 17:45, il y a 3 heures 56 minutes

Declaration of voting rights at the end of September 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 05/10/2026 à 14:45, il y a 6 heures 56 minutes

NanoViricides Provides Additional Details on the Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola as the Outbreak Continues to Expand and Has Taken Over 4,000 Lives
Publié le 05/10/2026 à 14:30, il y a 7 heures 11 minutes

Hillcrest and Equipmake Expand Partnership Talks to Include Commercial Licensing of ZVS Technology
Publié le 05/10/2026 à 14:30, il y a 7 heures 11 minutes

Solitario CEO to Present at John Tumazos Very Independent Research, LLC
Publié le 05/10/2026 à 14:00, il y a 7 heures 41 minutes

Tectonic Metals Appoints Eduard Epshtein as CFO, Bolstering Executive Team for Next Stage of Growth
Publié le 05/10/2026 à 14:00, il y a 7 heures 41 minutes

GameSquare to Present at Upcoming Investor Conferences

Voir tout ACCESSWIRE

EQS Group

Publié le 05/10/2026 à 21:10, il y a 31 minutes

Shelly Group Board of Directors considers EUR 70.00 offer price fair and supports Schneider Electric’s voluntary public tender offer
Publié le 05/10/2026 à 21:05, il y a 35 minutes

EQS-Adhoc: Shelly Group SE: Board of Directors with positive opinion on the registered voluntary public tender offer by Schneider Electric SE
Publié le 05/10/2026 à 20:15, il y a 1 heure 25 minutes

EQS-Adhoc: United Internet AG participates in capital increase against contributions in kind at 1&1 AG
Publié le 05/10/2026 à 20:09, il y a 1 heure 31 minutes

EQS-Adhoc: 1&1 AG resolves capital increase from authorized capital in exchange for a contribution in kind by United Internet AG
Publié le 05/10/2026 à 19:30, il y a 2 heures 11 minutes

EEII AG: Suspension of the Jubin Frères SA Reverse Takeover